Andrea E DeBarber1, Jenny Luo2, Roberto Giugliani3, Carolina F M Souza4, John Pei-Wen Chiang5, Louise S Merkens6, Anuradha S Pappu6, Robert D Steiner7. 1. Department of Physiology & Pharmacology, Oregon Health & Science University (OHSU), Portland, OR 97239, USA. Electronic address: debarber@ohsu.edu. 2. Department of Physiology & Pharmacology, Oregon Health & Science University (OHSU), Portland, OR 97239, USA. 3. Medical Genetics Service, Hospital de Clinicas de Porto Alegre, Brazil; Department of Genetics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 4. Department of Genetics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. 5. Casey Molecular Diagnostic Laboratory, OHSU, USA. 6. Department of Pediatrics, OHSU, USA. 7. Department of Pediatrics, OHSU, USA; Department of Molecular & Medical Genetics, Child Development & Rehabilitation Center, Doernbecher Children's Hospital, OHSU, USA; Marshfield Research Clinic Foundation, Marshfield, WI 54449, USA.
Abstract
OBJECTIVES: Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder of bile acid (BA) synthesis that can cause progressive neurological damage and premature death. Blood (normally serum or plasma) testing for CTX is performed by a small number of specialized laboratories, routinely by gas chromatography-mass spectrometry (GC-MS) measurement of elevated 5α-cholestanol. We report here on a more sensitive biochemical approach to test for CTX particularly useful for confirmation of CTX in the case of a challenging diagnostic sample with 5α-cholestanol that, although elevated, was below the cut-off used for diagnosis of CTX (10 μg/mL or 1.0 mg/dL). DESIGN AND METHODS: We have previously described liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) methodology utilizing keto derivatization to enable the sensitive quantification of plasma ketosterol BA precursors that accumulate in CTX. We have expanded this methodology to perform isotope dilution LC-ESI-MS/MS quantification of a panel of plasma ketosterol BA precursors, with internal standards readily generated using isotopically-enriched derivatization reagent. RESULTS: Quantification of plasma ketosterol BA precursors (7α-hydroxy-4-cholesten-3-one, 7α,12α-dihydroxy-4-cholesten-3-one and 7α,12α-dihydroxy-5β-cholestan-3-one) in a single LC-ESI/MS/MS test provided better discrimination between a CTX-positive and negative samples analyzed (n=20) than measurement of 5α-cholestanol alone. CONCLUSIONS: Quantification of plasma ketosterol BA precursors provides a more sensitive biochemical approach to discriminate between CTX negative and positive samples. A multiplexed LC-ESI-MS/MS test quantifying a panel of plasma ketosterols, with simple sample preparation, rapid analysis time and readily available internal standards, can be performed by most clinical laboratories. Wider availability of testing will benefit those affected with CTX.
OBJECTIVES:Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder of bile acid (BA) synthesis that can cause progressive neurological damage and premature death. Blood (normally serum or plasma) testing for CTX is performed by a small number of specialized laboratories, routinely by gas chromatography-mass spectrometry (GC-MS) measurement of elevated 5α-cholestanol. We report here on a more sensitive biochemical approach to test for CTX particularly useful for confirmation of CTX in the case of a challenging diagnostic sample with 5α-cholestanol that, although elevated, was below the cut-off used for diagnosis of CTX (10 μg/mL or 1.0 mg/dL). DESIGN AND METHODS: We have previously described liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) methodology utilizing keto derivatization to enable the sensitive quantification of plasma ketosterol BA precursors that accumulate in CTX. We have expanded this methodology to perform isotope dilution LC-ESI-MS/MS quantification of a panel of plasma ketosterol BA precursors, with internal standards readily generated using isotopically-enriched derivatization reagent. RESULTS: Quantification of plasma ketosterol BA precursors (7α-hydroxy-4-cholesten-3-one, 7α,12α-dihydroxy-4-cholesten-3-one and 7α,12α-dihydroxy-5β-cholestan-3-one) in a single LC-ESI/MS/MS test provided better discrimination between a CTX-positive and negative samples analyzed (n=20) than measurement of 5α-cholestanol alone. CONCLUSIONS: Quantification of plasma ketosterol BA precursors provides a more sensitive biochemical approach to discriminate between CTX negative and positive samples. A multiplexed LC-ESI-MS/MS test quantifying a panel of plasma ketosterols, with simple sample preparation, rapid analysis time and readily available internal standards, can be performed by most clinical laboratories. Wider availability of testing will benefit those affected with CTX.
Authors: M Kuriyama; J Fujiyama; H Yoshidome; S Takenaga; K Matsumuro; T Kasama; K Fukuda; T Kuramoto; T Hoshita; Y Seyama Journal: J Neurol Sci Date: 1991-04 Impact factor: 3.181
Authors: B J Koopman; J C van der Molen; B G Wolthers; A E de Jager; R J Waterreus; C H Gips Journal: Clin Chim Acta Date: 1984-03-13 Impact factor: 3.786
Authors: M G M de Sain-van der Velden; A Verrips; B H C M T Prinsen; M de Barse; R Berger; G Visser Journal: J Inherit Metab Dis Date: 2008-10-24 Impact factor: 4.982
Authors: Andrea E DeBarber; William E Connor; Anuradha S Pappu; Louise S Merkens; Robert D Steiner Journal: Clin Chim Acta Date: 2009-10-03 Impact factor: 3.786